Investigations of clofibrate in alternative carcinogenicity models

Michael J Santostefano1, Debie J Hoivik, Richard T Miller

  • 1GlaxoSmithKline, Safety Assessment, Research Triangle Park, North Carolina 27709, USA. michael.j.santostefano@gsk.com

Abstract

No abstract available in PubMed .